Home › Opioid Overdose › NCT05711056
Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
Expanding Rural Access to Opioid Use Disorder Treatment Utilizing Medical Toxicologists and the Georgia Poison Center to Facilitate Emergency Department- and Telehealth-Based Medication Initiation and Linkage to Care
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18 years or older * English speaking * Clinically sober * Medically and psychiatrically stable Exclusion criteria: * Already receiving MAT or psychotherapy for OUD prior to ED arrival * Prior participation in the study * Unable to provide informed consent * If their clinical condition worsens such that continued participation would be considered unsafe in the opinion of the PRC or ED staff * Prisoners * Individuals who are not yet adults (infants, children, teenagers) * Cognitively impaired or Individuals with Impaired Decision-Making Capacity * Individuals who are not able to clearly understand English
About the study
The overarching goal of this project is to increase the availability of OUD treatment in rural counties in the state of Georgia by using Emergency Department (ED)-based telehealth strategies to initiate MOUD and connect patients to treatment.
The investigators will implement a novel collaboration between rural EDs, medical toxicologists at the Georgia Poison Center (GPC), peer recovery coaches (PRCs) and RCOs throughout Georgia to bridge the gap between OUD treatment need in rural EDs and specialty physician availability at the GPC.
Research activities will be conducted during two broad phases, at three rural EDs in Georgia: planning and implementation. During the planning phase, aggregate data will be obtained to determine each ED's existing practices treating patients with OUD and opioid withdrawal. During the implementation phase, the researchers will prospectively study a poison center OUD consultation and PRC intervention as it is rolled out at each site, collecting participant-level data. Sites will be rolled into the implementation phase in a stepped-wedge fashion, so there will be times when some sites are in the planning phase while others are in the implementation phase.
What is being tested
- Sociobehavioral Intervention (behavioral)
Sponsor: Emory University · Participants: 480 · Started: Aug 30, 2023
Contact the study team
- Emily Kiernan, DO · Phone: 412-519-4944
Official record on ClinicalTrials.gov — NCT05711056
Locations in the U.S.
| Georgia | Georgia Poison Center, Atlanta |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.